This repositionable tape is simple to use and satisfies a long-unmet need for clinicians seeking reliable adhesion and soft, atraumatic removal, minimizing the likelihood of tape-related skin injury. 3M Kind Removal Silicone Tape released this week at the Wound Ostomy and Continence Nurses Culture meeting in New Orleans and will be available throughout the U tadalafilnorge.com . S beginning June 22, 2011. ‘This new tape represents the convergence of 3M’s 50 years of medical adhesive tape ‘know-how’ along with the ingenious use of our different advanced technology platform; it really is unmatched in the industry virtually,’ stated Simon Fung, Ph.D., 3M senior item development professional and inventor of 3M Silicone Tape. ‘Medical tape touches almost every patient each day.
It represents the hard work of many individuals working collaboratively as a team to achieve the common objective. We anticipate continuing success in our collaboration. .. 3SBio files APX001 IND application with SFDA in China Apexigen, Inc., an emerging biopharmaceutical company centered on the discovery and advancement of monoclonal antibody therapeutics, announced today that it is partner, 3SBio [SSRX] of Shenyang, China, filed an Investigational New Drug software for APX001, also known as SSS07, with the State Food and Medication Administration in China. Upon authorization of the IND, APX001/SSS07 will be studied in clinical trials for the treating autoimmune and inflammatory illnesses. APX001/SSS07 was discovered by using Apexigen’s proprietary monoclonal antibody systems and has been produced by 3SBio in China under a license from Apexigen.